A NATIONAL LEADER IN MEN’S SEXUAL HEALTH
Dr. Amy M. Pearlman offers medical and surgical therapies for men with erectile dysfunction, penile curvature, and testosterone deficiency, as well as transfeminine gender-affirming genital surgery. Though trained as a surgeon, Dr. Pearlman’s primary mission is to educate people on the basics of their bodies, encourage healthy behaviors to optimize health and help people live their most authentic lives.
I will exude enthusiasm and gratitude.
I will laugh loud and often. I will live life without regret.
I will inspire others to reach their goals with honesty and encouragement.
I will apologize when I mess up. I will be a team player. I will listen more and talk less.
I will seek out constructive criticism. I will dance, paint, write, and design.
I will dedicate my heart and skill to my patients.
I will love my family and friends
I will create the life I desire as if my life depends on it,
Because it does.
In living my life according to my personal mission statement, I will become a better person Everyday of my life
In every aspect of my life
For the rest of my life.
Davis JS, Allan BJ, Pearlman AM, Carvajal DP, Schulman CI. Optimal emergency personnel allocation after a natural disaster. American Journal of Disaster Medicine. 2012; 7(1):31-36.
Pastuszak AW, Pearlman AM, Godoy G, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in the setting of prostate cancer treated with radiation. Int J Impot Res. 2013; 25(1):24–28.
Pastuszak AW, Pearlman AM, Lai WS, Godoy G, Sathyamoorthy K, Liu JS, Miles BJ, Lipshultz LI, Khera M. Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol. 2013; 190(2):639–644.
Matz EL, Pearlman AM, Terlecki RP. Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions. Investig Clin Urol. 2018; 59(1):61-65.
Sandberg JM, Gray I, Pearlman A, Terlecki RP. An evaluation of the manufacturer and user facility device experience database that inspired the United States food and drug administration’s reclassification of transvaginal mesh. Investig Clin Urol. 2018; 59(2): 126–132.
Pearlman AM, Rasper AM, Terlecki RP. Proof of concept: Exposing the myth of urethral atrophy after artificial urinary sphincter via assessment of circumferential recovery after capsulotomy and intraoperative pressure profiling of the pressure regulating balloon. Investig Clin Urol. 2018; 59(4):275-279.
McAbee K, Pearlman A, Terlecki R. Infection following penile prosthesis placement at an academic training center remains low despite involvement of surgeons-in-training. Investig Clin Urol. 2018; 59(5):342-347.
Pearlman A, Mujumdar V, McAbee K, Terlecki R. Outcomes of adult urethroplasty with commercially available acellular matrix. Ther Adv Urol. 2018;10(11):351-355.
Pearlman AM, Rukstalis D, Terlecki RP. Diagnosis and treatment of urethrocavernous fistula presenting as urethral bleeding. Urology. 2018; 120(E5).
Matz E, Pearlman A, MacDonald S, Colaco M, Terlecki R. Postoperative bleeding ranks highest among complications after RPLND: data from the National Surgical Quality Improvement Program. The American Surgeon. 2018; 84(12): e547-548.
Grimes MD, Tesdahl BA, Schubbe M, Dahmoush L, Pearlman AM, Kreder KJ, Erickson BA. Histopathology of anterior urethral strictures: toward a better understanding of stricture pathophysiology. J Urol. 2019; 202:1-9.
McAbee KE, Pearlman AM, Deebel NA, Rasper AM, Terlecki RP. Unplanned in-global clinic visits, emergency department encounters and hospital readmissions following urological prosthetic surgery: data for quality improvement. Urology Practice. 2020; 7(2):132-137.
Woodroffe, RW, Pearson, AC, Pearlman, AM,
Botkin H, Barnes B, Pearlman, A. Bulbar urethrocavernous fistula in setting of inflatable penile prosthesis: a case report. BMC Urol. 2021; 21, 25.
Peters M, Pearlman A
Cassim F, Pearlman A, Matz EL, Terlecki R, Lloyd Cecilia, Kowlessur B, Lazarus J, van der Merwe A. Trends in testicular germ cell tumors among native black African men do not mirror those of African Americans: Multi-institutional data from South Africa. Afr J Urol. 2021; 27, 53.
Gannon M, Pearlman A. Corporal body herniation during treatment with Xiaflex (collagenase histolyticum) for Peyronie’s Disease. BMC Urol. 2021; 21, 94.
Troesch V, Juhr D, Pearlman A. Barriers to receiving testosterone replacement therapy in the community during COVID-19 pandemic. Translational Andrology and Urology. 2021; 10(8): 3312-3316.
Studt A, Gannon M, Orzel J, Vaughan A, Pearlman AM. Characterizing post-SSRI sexual dysfunction and its impact on quality of life through an international online survey. I
Healy D, Bahrick A, Bak M, Barbato A, Calabro R, Chubak B, Cosci F, Csoka A, D’Aavanzo B, Diviccaro S, Giatti S, Goldstein I, Graf H, Hellstrom W, Irwig M, Jannnini E, Janssen P, Khera M, Kumar M, Le Noury J, Lew-Starowicz M, Linden D, Luning C, Mangin D, Melgangi R, Rodriguez O, Panicker J, Patacchini A, Pearlman AM, Pukall C, Raj S, Reisman Y, Rubin R, Schreiber R, Shipko S, Vaseckova B, Waraich A. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. International Journal of Risk & Safety in Medicine. 2021.
